151 related articles for article (PubMed ID: 15099288)
1. Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets.
Dorsam RT; Tuluc M; Kunapuli SP
J Thromb Haemost; 2004 May; 2(5):804-12. PubMed ID: 15099288
[TBL] [Abstract][Full Text] [Related]
2. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
4. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP
J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446
[TBL] [Abstract][Full Text] [Related]
5. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
[TBL] [Abstract][Full Text] [Related]
6. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-induced Akt activation--regulation and possible function.
Reséndiz JC; Kroll MH; Lassila R
J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
[TBL] [Abstract][Full Text] [Related]
8. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets.
Harper MT; Poole AW
J Thromb Haemost; 2011 Aug; 9(8):1599-607. PubMed ID: 21649850
[TBL] [Abstract][Full Text] [Related]
9. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152
[TBL] [Abstract][Full Text] [Related]
11. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.
Lova P; Campus F; Lombardi R; Cattaneo M; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2004 Jun; 279(24):25299-306. PubMed ID: 15078882
[TBL] [Abstract][Full Text] [Related]
12. Annexin V binding to platelets is agonist, time and temperature dependent.
Ramstrom S; O'Neill S; Dunne E; Kenny D
Platelets; 2010; 21(4):289-96. PubMed ID: 20230207
[TBL] [Abstract][Full Text] [Related]
13. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y
Whitley MJ; Henke DM; Ghazi A; Nieman M; Stoller M; Simon LM; Chen E; Vesci J; Holinstat M; McKenzie SE; Shaw CA; Edelstein LC; Bray PF
J Thromb Haemost; 2018 Dec; 16(12):2501-2514. PubMed ID: 30347494
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the distinct mechanism of agonist-induced canine platelet activation.
Chaudhary PK; Kim S
J Vet Sci; 2019 Jan; 20(1):10-15. PubMed ID: 30541187
[TBL] [Abstract][Full Text] [Related]
17. The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities.
Frelinger AL; Jakubowski JA; Li Y; Barnard MR; Linden MD; Tarnow I; Fox ML; Sugidachi A; Winters KJ; Furman MI; Michelson AD
J Thromb Haemost; 2008 Feb; 6(2):359-65. PubMed ID: 18021304
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1.
Keuren JF; Wielders SJ; Ulrichts H; Hackeng T; Heemskerk JW; Deckmyn H; Bevers EM; Lindhout T
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1499-505. PubMed ID: 15845904
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
Ramström S; Rånby M; Lindahl TL
Thromb Res; 2003 Mar; 109(5-6):315-22. PubMed ID: 12818256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
